Prakash Radhakrishnan
Assistant Professor
Institute for Research in Cancer and Allied Diseases
University of Nebraska Medical Center
United States of America
Biography
Dr. Prakash Radhakrishnan is an Assistant Professor, Eppley Institute Member Fred & Pamela Buffett Cancer Center Department of Biochemistry and Molecular Biology Department of Genetics, Cell Biology and Anatomy Department of Pathology and Microbiology
Research Interest
Glycobiology of Pancreatic Cancer Autocrine and paracrine Cell signaling mechanisms Developing new therapeutics for Pancreatic Cancer
Publications
-
Liu X, Caffrey TC, Steele MM, Mohr A, Singh PK, Radhakrishnan P, Kelly DL, Wen Y, Hollingsworth MA (2014) MUC1 regulates cyclin D1 gene expression through p120 catenin and β-catenin.
-
Radhakrishnan P, Dabelsteen S, Madsen FB, Francavilla C, Kopp KL, Steentoft C, Vakhrushev SY, Olsen JV, Hansen L, Bennett EP, Woetmann A, Yin G, Chen L, Song H, Bak M, Hlady RA, Peters SL, Opavsky R, Thode C, Qvortrup K, Schjoldager KT, Clausen H, Hollingsworth MA, Wandall HH (2014) Immature truncated O-glycophenotype of cancer directly induces oncogenic features.
-
Pandey P, Rachagani S, Das S, Seshacharyulu P, Sheinin Y, Naslavsky N, Pan Z, Smith BL, Peters HL, Radhakrishnan P, McKenna NR, Giridharan SS, Haridas D, Kaur S, Hollingsworth MA, MacDonald RG, Meza JL, Caplan S, Batra SK, Solheim JC (2015) Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis.
